• Dec 8th at 13:00 | Speakers: Laura McCoubrey, Dr Masoud Jamei | Chair: TBC
The APS Emerging Technologies Focus Group, is pleased to announce their webinar which will offer plenty of opportunities for discussions. This meeting will bring together expert speakers from academia and industry and will include a talk from a junior researcher and a talk from a senior researcher from industry or academia.
Who should attend
This meeting is ideally suited for PhD Candidates, Academics, Industrialists, Specialist Technology Providers, and Regulatory Personnel. Overall, the content of this special series has been carefully crafted to complement the existing APS portfolio and the Emerging Technologies Focus Group hot topics.
8th December 2022 – 13.00-14.00 UK Time/14.00-15.00 CET
Laura is a PhD researcher, fully funded within the EPSRC’s CDT in Transformative Pharmaceutical Technologies. Her research focuses on using machine learning technology to identify and predict drug-microbiome interactions. Laura has contributed to multiple book chapters, original research articles, and reviews. Her PhD is sponsored by Pfizer, and she is supervised by Prof. Abdul Basit, Prof. Simon Gaisford, and Dr Mine Orlu. Prior to her PhD, Laura worked in the NHS as a STEP London pharmacist. She qualified as a pharmacist at Oxford University Hospitals in 2018 and gained her first class MPharm degree from The University of Nottingham in 2017.
Dr Masoud Jamei, Senior Vice President of Research and Development at Simcyp, Division of Certara UK Limited
Masoud Jamei is the Senior Vice President of Research and Development at Simcyp Division of Certara UK Limited. He leads a team of around 50 scientists and 30 software developers and testers focusing on the design, development and implementation of various aspects of systems pharmacology models. His active areas of research include in vitro-in vivo extrapolation techniques, Physiologically-Based Pharmacokinetics / Pharmacodynamics (PBPK/PD) models of small and large molecules and applying top-down Population PK (PopPK) data analysis to PBPK models in healthy volunteer and patient populations. He has been the author or co-author of over 100 manuscripts and book chapters and over 165 abstracts in the field of modelling and biosimulation. He has been an invited speaker and a session organiser/moderator at national and international meetings and also leads well-known Simcyp hands-on workshops on model-informed drugs development. In 2002 he earned a PhD in Control Systems Engineering at the University of Sheffield, UK, and carried out one year of post-doctoral research there. He was an Honorary Lecturer at the University of Sheffield (2008-2011) and a visiting Senior Lecturer at the University of Manchester (2011-2014). In recognition of his professional excellence and sustained superior impact in field of pharmaceutical sciences he became AAPS Fellow in 2022. In 2003 he joined Simcyp Limited.
APS Members- Free
(Please get your code from the members hub for FREE tickets)
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.